Healthcare analytics company recognized for synchronizing clinical and genomics data in real time, enabling orchestration of timely patient care
SAN DIEGO – January 3, 2018 – Interpreta, Inc., an analytics company that intelligently synchronizes healthcare, has been recognized as one of the Top 10 Genomics Solution Providers - 2017 by Pharma Tech Outlook Magazine. Interpreta is featured in the magazine’s Genomics Special issue for “pioneering continuous treatment optimization” by interpreting genomic, clinical, and other patient data to improve clinical outcomes.
Pharma Tech Outlook actively tracked and reviewed reports, industry news, social media, surveys, and conducted independent research to narrow the 300 nominations. A panel of experts and members of Pharma Tech Outlook’s editorial board selected and finalized the top 10.
“We take pride in honoring Interpreta as one of the top 10 innovative companies specializing in providing genomics solutions for pharmaceutical companies,” says Stacey Smith, managing editor of Pharma Tech Outlook.
Interpreta continuously interprets clinical data at both the individual and population levels, while considering the unique genomic make-up of an individual to guide personalized treatment plans and enable better healthcare outcomes. Interpreta leverages continuously updated, FDA-published knowledge, as well as guidelines from The National Committee for Quality Assurance (NCQA) and Centers for Medicare and Medicaid Services (CMS), to manage quality of care, pharmacogenomics, medication adherence, and safety within a single system.
Interpreta CEO and Co-founder Ahmed Ghouri, M.D. says the healthcare industry is constantly seeking ways to optimize treatment options and that Interpreta sees analyzing genomics data along with clinical data and FDA-published knowledge as the best path to meet that goal.
“When genomics data is combined with clinical and FDA guidelines and continuously updated, healthcare providers get the prospective information they need to orchestrate timely care and improve quality,” says Dr. Ghouri “We are happy to be recognized as being at the forefront of genomics and healthcare analytics, and for turning the holy grail of continuous treatment optimization into a reality.”
Published in Fremont, California, Pharma Tech Outlook is a monthly magazine that covers the most important and latest developments in the pharmaceutical industry.
Interpreta enables precision medicine by continuously interpreting and synchronizing clinical and genomics data in real time, creating a personalized roadmap, and enabling the orchestration of timely care. This provides physicians, patients, care managers, and healthcare organizations with the patient-specific information needed for improved quality, patient prioritization, population management, and personalized medicine. To learn more, visit us at www.interpreta.com or email us at firstname.lastname@example.org. Follow us on Twitter @InterpretaInc and LinkedIn.